This activity is supported by educational funding provided by Amgen.
Effective pharmacologic treatment options are now available for the 10 million men and women in the United States diagnosed with osteoporosis; the goal of such pharmacologic therapy is to reduce the risk of fractures. Several classes of medications are available, and while they may have overlapping indications, not all are approved by the US Food and Drug Administration to treat postmenopausal osteoporosis, osteoporosis in men, or glucocorticoid-induced osteoporosis. Although the safety and efficacy of these treatments have been well established, few comparative head-to-head studies exist, and those that are available suggest some differences in efficacy with respect to fracture risk reduction. In this myCME™ case Clinic, an osteoporosis expert will offer recommendations on initiating the most appropriate therapy for patients with osteoporosis, as well as incorporating shared decision-making into the treatment-selection process.
Primary audience: Family physicians
Secondary audience: Endocrinologists, internists, obstetrician-gynecologists, nurse practitioners, and physician assistants who manage the care of patients with or at risk for osteoporosis
At the conclusion of this activity, participants should be better able to:
Identify the risks and benefits of pharmacologic agents for patients with osteoporosis
Apply guideline recommendations to identify individuals at risk for osteoporosis and to individualize treatment
Implement patient education and shared decision-making to optimize osteoporosis treatment and outcomes
Conflict Of Interest Disclosure Policies
In accordance with the ACCME Standards for Commercial Support, HME requires that individuals in a position to control the content of an educational activity disclose all relevant financial relationships with any commercial interest. HME resolves all conflicts of interest to ensure independence, objectivity, balance, and scientific rigor in all its educational activities.
Andrea J. Singer, MD, FACP, CCD Director, Women’s Primary Care Director, Bone Densitometry Departments of Obstetrics and Gynecology and Medicine MedStar Health Georgetown University Hospital Washington, DC
Dr. Singer is a consultant for AgNovos Healthcare, Amgen, Eli Lilly, Radius Health, Inc., and UCB, Inc. She is on the speakers’ bureaus for Amgen, Eli Lilly, and Radius Health, Inc., and receives research grant funds from Radius Health, Inc.
Accredited Provider Disclosures
Haymarket Medical Education staff involved in the planning and content review of this activity have no relevant financial relationships to disclose.
AMA PRA Category 1 Credit(s)TM
Haymarket Medical Education is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
Haymarket Medical Education designates this enduring material for a maximum of 0.50 AMA PRA Category 1 CreditTM . Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Additional Credit Information
Physician Assistant Continuing Education AAPA accepts certificates of participation for educational activities approved for AMA PRA Category 1 CreditTM from organizations accredited by ACCME or a recognized state medical society. PAs may receive a maximum of 0.50 Category 1 Credit for completing this activity.
Nurse Practitioner Continuing Education AANPCP accepts certificates of participation for educational activities approved for AMA PRA Category 1 CreditTM from organizations accredited by ACCME. Individuals are responsible for checking with the AANPCP for further guidelines.
Disclosure of Unlabeled Use
This CME activity may or may not discuss investigational, unapproved, or off-label use of drugs. Participants are advised to consult prescribing information for any products discussed. The information provided in this CME activity is for continuing medical education purposes only and is not meant to substitute for the independent medical judgment of a physician relative to diagnostic and treatment options for a specific patient’s medical condition.
The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of Haymarket Medical Education or Amgen. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
To obtain credit, a score of 70% or better on the post-test is required. This activity is offered at no cost to participants. Please proceed with the activity until you have successfully completed this program, answered all test questions, completed the post-test and evaluation, and have received a digital copy of your credit certificate. Your online certificate will be saved on myCME within your Profile/CME History, which you can access at any time.